SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 120 Minutes

Overview

This interactive program will educate participants to chart, code, and bill properly for three common cancers. Expert faculty will identify key pertinent information for each cancer diagnosis and describe how to properly chart in each section of a standard progress note. Participants will be guided through each case study, from the patient visits to reimbursement, reviewing proper coding and billing. This program will help improve the learners’ note-taking and relationships with multidisciplinary groups and optimize reimbursement.

Learning Objectives

1. Assess results from recent clinical trials and real-world evidence studies of emerging therapeutic strategies for chronic rhinosinusitis with nasal polyps (CRSwNP) and how biologics fit into the treatment landscape
2. Identify emerging response biomarkers to biologics and their potential role in guiding treatment decisions of CRSwNP
3. Implement monitoring parameters and management strategies for adverse events associated with biologics in patients with CRSwNP
4. Apply effective strategies to optimize treatment of CRSwNP

Target Audience

The primary audience is otolaryngologists (MD/DO) and mid-level providers who specialize in otolaryngology including nurse practitioners (NP) and physician assistants (PA). The secondary audience is Allergists and Pulmonologists, Internal Medicine, Primary Care and Rural providers.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.